Skip to main content
Log in

Increased ILT2+ natural killer T cells correlate with disease activity in systemic lupus erythematosus

  • ORIGINAL ARTICLE
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Objective

Numerous immune cell types, such as B and T lymphocytes, natural killer cells (NK), and NKT cells, are related to the pathogenesis of diseases in systemic lupus erythematosus (SLE). Our goal in this investigation is to examine the phenotype of NK cells and NKT cells alterations in individuals with SLE.

Methods

Typically, 50 SLE patients and 24 age-matched healthy people had their PBMCs obtained. Employing flow cytometry, the phenotype of NK and NKT cells and immunoglobulin-like transcript 2 (ILT2) expressions were identified. ELISA was utilized to evaluate the amounts of interleukin-15 (IL-15) and sHLA-G in the serum.

Results

The frequencies of the circulating NK and NKT cells in individuals with SLE were decreased compared to healthy controls. Furthermore, ILT2 expression was significantly increased in NKT cells, but showed no obvious change in NK cells. Clinical severity and active nephritis were substantially associated with ILT2+ NKT cell frequencies. The correlation study showed that the upregulation of ILT2 expression was related to sHLA-G in plasma but not to IL-15.

Conclusions

ILT2+ NKT cells have a vital function in the immune abnormalities of SLE, which can also supply a viable goal for therapeutic intervention.

Key Points

ILT2 expression was significantly increased in NKT cells in SLE patients.

ILT2+ NKT cell frequencies were associated with clinical severity which may be used as an indicator for evaluating disease activity in patients with SLE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

References

  1. Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365:2110–2121

    Article  CAS  PubMed  Google Scholar 

  2. Dörner T, Furie R (2019) Novel paradigms in systemic lupus erythematosus. Lancet 393(10188):2344–2358

    Article  PubMed  Google Scholar 

  3. Suarez-fueyo A, Bradley SJ, Tsokos GC (2016) T cells in systemic lupus erythematosus. Curr Opin Immunol 43:32–38

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Hervier B, Beziat V, Haroche J, Mathian A, Lebon P, Ghillani-Dalbin P et al (2011) Phenotype and function of natural killer cells in systemic lupus erythematosus. Arthritis Rheum 63(6):1698–1706

    Article  CAS  PubMed  Google Scholar 

  5. Spada R, Rojas JM, Barber DF (2015) Recent findings on the role of natural killer cells in the pathogenesis of systemic lupus erythematosus. J Leukoc Biol 98(4):479–487

    Article  CAS  PubMed  Google Scholar 

  6. Park YW, Kee SJ, Cho YN, Lee EH, Lee HY, Kim EM et al (2009) Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis rheum 60:1753–1763

    Article  CAS  PubMed  Google Scholar 

  7. Godfrey DI, Stankovic S, Baxter AG (2010) Raising the NKT cell family. Nat immunol 11:197–206

    Article  CAS  PubMed  Google Scholar 

  8. Green MR, Kennell AS, Larche MJ, Seifert MH, Isenberg DA, Salaman MR (2007) Natural killer T cells in families of patients with systemic lupus erythematosus: their possible role in regulation of IGG production. Arthritis rheum 56:303–310

    Article  PubMed  Google Scholar 

  9. Zhuang Y, Ning M, Ling Z, Zhen-Yu J, Yan-Fang J (2016) Differential expression of natural killer activating and inhibitory receptors in patients with newly diagnosed systemic lupus erythematosus. Int J Rheum Dis 19(6):613–621

    Article  Google Scholar 

  10. Lucia N, Cristiana B, Cristina C, Serena R, Fulvia C, Marta V et al (2023) KLRG1 is reduced on NK cells in SLE patients, inversely correlates with disease activity and is modulated by hydroxychloroquine in vitro. Lupus 32(4):549–559

    Article  Google Scholar 

  11. de Cruz-González DJ, Gómez-Martin D, Layseca-Espinosa E, Baranda L, Abud-Mendoza C, Alcocer-Varela J et al (2018) Analysis of the regulatory function of natural killer cells from patients with systemic lupus erythematosus. Clin Exp Immunol 191(3):288–300

    Article  PubMed  Google Scholar 

  12. Bellón T, Kitzig F, Sayós J, López-Botet M (2002) Mutational analysis of immunoreceptor tyrosine-based inhibition motifs of the Ig-like transcript 2 (CD85j) leukocyte receptor. J Immunol 168:3351–3359

    Article  PubMed  Google Scholar 

  13. Lamar DL, Weyand CM, Goronzy JJ (2010) Promoter choice and translational repression determine cell type-specific cell surface density of the inhibitory receptor CD85j expressed on different hematopoietic lineages. Blood 115:3278–3286

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725

    Article  CAS  PubMed  Google Scholar 

  15. Zahran AM, Abdel-Rahim MH, Elsayh KI, Hassanien MM, Mahran SA, Hetta HF (2019) Natural killer and natural killer t cells in juvenile systemic lupus erythematosus: relation to disease activity and progression. Arch Immuno Ther Ex 67:161–169

    Article  CAS  Google Scholar 

  16. Liu M, Liu J, Zhang X, Xiao Y, Jiang G, Huang X (2021) Activation status of CD56(dim) natural killer cells is associated with disease activity of patients with systemic lupus erythematosus. Clin Rheumatol 40:1103–1112

    Article  PubMed  Google Scholar 

  17. Lin SJ, Kuo ML (2011) Cytotoxic function of umbilical cord blood natural killer cells: relevance to adoptive immunotherapy. Pediatr Hemat Oncol 28:640–646

    Article  CAS  Google Scholar 

  18. Godfrey DI, Macdonald HR, Kronenberg M, Smyth MJ, Van Kaer L (2004) NKT cells: what’s in a name? Nat Rev Immunol 4:231–237

    Article  CAS  PubMed  Google Scholar 

  19. Lu Z, Tian Y, Bai Z, Liu J, Zhang Y, Qi J, Jin M, Zhu J, Li X (2022) Increased oxidative stress contributes to impaired peripheral CD56dimCD57+ NK cells from patients with systemic lupus erythematosus. Arthritis Res Ther 24(1):48

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Manman L, Junli L, Xiaoyan Z, Yichuan X, Gengru J, Xinfang H (2021) Activation status of CD56dim natural killer cells is associated with disease activity of patients with systemic lupus erythematosus. Clin Rheumatol 40:1103–1112

    Article  Google Scholar 

  21. Bosma A, Abdel-Gadir A, Isenberg DA, Jury EC, Mauri C (2012) Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells. Immunity 36:477–490

    Article  CAS  PubMed  Google Scholar 

  22. Qing L, Yunyuan K, Biqi F, Xue L, Qingshui H, Zikun H et al (2022) Increased TIM-3+PD-1+ NK cells are associated with the disease activity and severity of systemic lupus erythematosus. Clin Exp Med 22(1):47–56

    Article  Google Scholar 

  23. Hudspeth K, Wang S, Wang J, Rahman S, Smith MA, Casey KA et al (2019) Natural killer cell expression of Ki67 is associated with elevated serum IL-15, disease activity and nephritis in systemic lupus erythematosus. Clin Exp Immunol 196:226–236

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Wong PT, Wong CK, Tam LS, Li EK, Chen DP, Lam CW (2009) Decreased expression of T lymphocyte co-stimulatory molecule CD26 on invariant natural killer T cells in systemic lupus erythematosus. Immunol Invest 38:350–364

    Article  CAS  PubMed  Google Scholar 

  25. Monsiváis-urenda A, Niño-moreno P, Abud-mendoza C, Baranda L, Layseca-espinosa E, López-botet M (2007) Analysis of expression and function of the inhibitory receptor ILT2 (CD85j/LILRB1/LIR-1) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus (SLE). J Autoimmun 29:97–105

    Article  PubMed  Google Scholar 

  26. Figueroa-vega N, Galindo-rodríguez G, Bajaña S, Portales-Pérez D, Abud-mendoza C, Sánchez-torres C et al (2006) Phenotypic analysis of IL-10-treated, monocyte-derived dendritic cells in patients with systemic lupus erythematosus. Scand J Immunol 64:668–676

    Article  CAS  PubMed  Google Scholar 

  27. Chen J, Shen B, Jiang Y, Jun L, Zhu M, Chen B et al (2013) Analysis of immunoglobulin-like transcripts (ILTs) in lymphocytes with sHLA-G and IL10 from SLE patients. Clin Exp Med 13:135–142

    Article  CAS  PubMed  Google Scholar 

  28. Huntington ND, Legrand N, Alves NL, Jaron B, Weijer K, Plet A et al (2009) IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med 206:25–34

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Lin SJ, Kuo ML, Hsiao HS, Lee PT, Chen JY, Huang JL (2017) Activating and inhibitory receptors on natural killer cells in patients with systemic lupus erythematosis-regulation with interleukin-15. PLoS One 12:e0186223

    Article  PubMed  PubMed Central  Google Scholar 

  30. Lin SJ, Kuo ML, Hsiao HS, Lee PT, Lee WI, Chen JY et al (2019) Cytotoxic function and cytokine production of natural killer cells and natural killer t-like cells in systemic lupus erythematosis regulation with interleukin-15. Mediators Inflamm 2019:4236562

    Article  PubMed  PubMed Central  Google Scholar 

  31. D’almeida TC, Sadissou I, Cottrell G, Tahar R, Moreau P, Favier B et al (2016) Evolution of the levels of human leukocyte antigen G (HLA-G) in Beninese infant during the first year of life in a malaria endemic area: using latent class analysis. Malaria J 15:78

    Article  Google Scholar 

  32. Rezaieyazdi Z, Rezaeian A, Khodashahi M (2023) Serum level of soluble human leukocyte antigen G in patients with systemic lupus erythematosus and rheumatoid arthritis. Curr Rheumatol Rev 19(1):64–71

    Article  CAS  PubMed  Google Scholar 

  33. Bae SC, Lee YH (2021) Association of HLA-G polymorphisms with systemic lupus erythematosus and correlation between soluble HLA-G levels and the disease: a meta-analysis. Z rheumatol 80:96–102

    Article  PubMed  Google Scholar 

Download references

Funding

This study was supported by Natural Science Foundation of Fujian (no. 2022J011004, 2023J011178), Suzhou “Kejiaoxingwei” Youth Science and Technology project (KJXW2020004), and the Medical Innovation Project of Fujian (no. 2022CXB001).

Author information

Authors and Affiliations

Authors

Contributions

Ning Chen and Yijun Dai conceived and coordinated the study and wrote the paper. Qing Yan, Jun Ke, Jiuyun Zhang, and Hong Sun designed, performed and analyzed the experiments. Hui Li, Xianming Long, Fei Gao, and He Lin carried out the data collection, data analysis, and revised the paper. All authors reviewed the results and approved the final version of the manuscript.

Corresponding authors

Correspondence to Hong Sun, Fei Gao or Qing Yan.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the ethics committee of Fujian Provincial Hospital. Written informed consent was obtained from all participants.

Disclosures

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, N., Dai, Y., Li, H. et al. Increased ILT2+ natural killer T cells correlate with disease activity in systemic lupus erythematosus. Clin Rheumatol 42, 3113–3121 (2023). https://doi.org/10.1007/s10067-023-06750-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-023-06750-1

Keywords

Navigation